Elucidating the Impact of Thermodynamic Hydrate Inhibitors and Kinetic Hydrate Inhibitors on a Complex System of Natural Gas Hydrates: Application in Flow Assurance

Abstract

To alleviate the hydrate blockage risk in oil and gas pipelines/production facilities, thermodynamic hydrate inhibitors (THIs) and kinetic hydrate inhibitors (KHIs) are the frequently used additives/chemicals. While these additives are highly effective, the impact of low dosage of THIs (under inhibited systems) and performance of KHIs at high water cut and/or high subcooling is not well understood. In this work, a high-pressure visual stirred tank reactor was employed to investigate the impact of THIs and KHIs on the kinetics of the complex hydrates of natural gas mixtures (CH4/C2H6/C3H8) and cyclopentane at high water-cut and high subcooling (∼21 °C). Various concentrations of a THI, mono-ethylene glycol (MEG) with a dosage ranging from 0.1 to 25 wt %, and multiple KHIs (polyvinylpyrrolidone (PVP k-30, PVP k-90), caprolactam, butyl glycol ether (BGE), and polyglycerin with 0.1 wt % dosage) were evaluated for hydrate formation kinetics, onset hydrate formation/nucleation temperature, and morphological changes. Gas uptake results reveal that hydrate blockage risk is higher at low MEG content (0.1 to 10 wt %) compared to the baseline, while a significant reduction in gas uptake was observed for the high MEG content trials (20–25 wt %). With 20 and 25 wt % MEG, the hydrate nucleation temperature was reduced by 10–12 °C compared to the baseline. In context to KHIs impact, 0.1 wt % BGE and caprolactam promoted the nucleation temperature and the rate of hydrate formation/gas uptake. However, PVPs not only reduced the gas uptake kinetics but also lessened the hydrate nucleation temperature by 6–8 °C compared to the baseline data. Our results may offer new insights into optimizing hydrate inhibitors dosage to diminish the risk of hydrate blockage in subsea pipelines.